The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment

BACKGROUND: Artemisinin resistance is a major threat to current efforts to eliminate Plasmodium falciparum malaria which rely heavily on the continuing efficacy of artemisinin combination therapy (ACT). It has been suggested that ACT should not be used in mass drug administration (MDA) in areas wher...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Maude, R, Nguon, C, Dondorp, A, White, L, White, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	BioMed Central 2014

Παρόμοια τεκμήρια

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2003)

Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
ανά: McKeage, K, κ.ά.
Έκδοση: (2003)

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
ανά: Färnert, A, κ.ά.
Έκδοση: (2003)

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
ανά: van Vugt, M, κ.ά.
Έκδοση: (2002)

Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2003)

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
ανά: Lacy, MD, κ.ά.
Έκδοση: (2002)

Early treatment failure during treatment of <it>Plasmodium falciparum</it> malaria with atovaquone-proguanil in the Republic of Ivory Coast
ανά: Wurtz Nathalie, κ.ά.
Έκδοση: (2012-05-01)

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru
ανά: A. Llanos-Cuentas, κ.ά.

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
ανά: Maude, R, κ.ά.
Έκδοση: (2012)

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
ανά: Ling, J, κ.ά.
Έκδοση: (2002)

Mutations in the <it>Plasmodium falciparum cytochrome b </it>gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
ανά: Fivelman Quinton L, κ.ά.
Έκδοση: (2008-11-01)

Absence of an interaction between artesunate and atovaquone--proguanil.
ανά: van Vugt, M, κ.ά.
Έκδοση: (1999)

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2005)

Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
ανά: Butcher, G, κ.ά.
Έκδοση: (2000)

Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
ανά: Jenny Lea Schnyder, κ.ά.
Έκδοση: (2025-03-01)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed <it>Plasmodium falciparum </it>isolates from Africa
ανά: Kyle Dennis E, κ.ά.
Έκδοση: (2006-10-01)

Detection of atovaquone-proguanil resistance conferring mutations in <it>Plasmodium falciparum </it>cytochrome b gene in Luanda, Angola
ανά: Varandas Luís, κ.ά.
Έκδοση: (2006-04-01)

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
ανά: Enosse, S, κ.ά.
Έκδοση: (2000)

<it>In vitro </it>atovaquone/proguanil susceptibility and characterization of the <it>cytochrome b </it>gene of <it>Plasmodium falciparum </it>from different endemic regions of Thailand
ανά: Mungthin Mathirut, κ.ά.
Έκδοση: (2008-01-01)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.
ανά: Beatrix Huei-Yi Teo, κ.ά.
Έκδοση: (2015-01-01)

Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
ανά: Gupta, R, κ.ά.
Έκδοση: (2005)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
ανά: Laurencie Massamba, κ.ά.
Έκδοση: (2020-01-01)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
ανά: Staines, H, κ.ά.
Έκδοση: (2017)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
ανά: Anja Wiegmann, κ.ά.
Έκδοση: (2022-07-01)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
ανά: V Nicosia, κ.ά.
Έκδοση: (2008-09-01)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
ανά: Chiodini, P, κ.ά.
Έκδοση: (1995)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
ανά: Chotivanich, K, κ.ά.
Έκδοση: (2012)

Atovaquone-Proguanil: A Promising Therapy for Persistent Relapsing Babesiosis
ανά: Mahum Shahid, κ.ά.
Έκδοση: (2024-01-01)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
ανά: Kathrine R. Tan, κ.ά.
Έκδοση: (2018-05-01)

The effects of serum lipids on the <it>in vitro</it> activity of lumefantrine and atovaquone against <it>Plasmodium falciparum</it>
ανά: Chotivanich Kesinee, κ.ά.
Έκδοση: (2012-05-01)

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
ανά: Brady, O, κ.ά.
Έκδοση: (2017)

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.
ανά: Miriam K Laufer, κ.ά.
Έκδοση: (2012-01-01)

OPTIMISING STRATEGIES FOR MALARIA ELIMINATION: PRIMAQUINE, MASS DRUG ADMINISTRATION AND ARTEMISININ RESISTANCECATEGORY: SCIENTIFIC FREE PAPER
ανά: Maude, R, κ.ά.
Έκδοση: (2011)

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
ανά: Krudsood, S, κ.ά.
Έκδοση: (2005)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
ανά: Ivanovic Jelena, κ.ά.
Έκδοση: (2011-05-01)

Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil
ανά: JP Dean Goldring, κ.ά.
Έκδοση: (1999-09-01)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by <i>Plasmodium relictum</i> in Snowy Owl (<i>Bubo scandiacus</i>)
ανά: Nicola Pugliese, κ.ά.
Έκδοση: (2023-11-01)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
ανά: Dondorp, A, κ.ά.
Έκδοση: (2009)

Estudo comparativo entre uma combinação de atovaquone mais proguanil e um regime de quinino mais tetraciclina no tratamento de malária aguda por Plasmodium falciparum em adultos no Brasil
ανά: Filomena Euridice Carvalho de Alencar
Έκδοση: (1999-04-01)

Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies.
ανά: Tripura, R, κ.ά.
Έκδοση: (2016)